What is Amplitech Group, Inc. Series B Right's earnings per share (EPS)?

Amplitech Group, Inc. Series B Right (AMPGZ) reported diluted earnings per share of -$0.33 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amplitech Group, Inc. Series B Right (AMPGZ) Financials

AMPGZ

FY2025 annual

Revenue $25.2M +165.0% YoY

Net Income -$7.0M +37.7% YoY

EPS (Diluted) -$0.33 YoY not available

Free Cash Flow -$9.7M -81.7% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMPGZ SEC filings page.

Amplitech Group, Inc. Series B Right (AMPGZ) reported $25.2M in revenue for fiscal year 2025, up 165.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMPGZ FY2025 2026-08-29

AMPGZ’s dominant mechanic is a volume rebound overwhelmed by cost intensity, leaving growth coupled with deeper cash consumption and tighter short-term flexibility.

Revenue rebounded sharply in FY2025, but gross margin compressed from 36.7% in FY2024 to 23.9%; the recovery therefore arrived with a weaker margin structure rather than clean operating improvement. The cash requirement exceeded the reported loss: operating cash flow was -$8.7M against net loss of -$7.0M, indicating that reported earnings understated the resources consumed in the year.

Operating costs outran gross profit in FY2025: SG&A was $10.7M versus gross profit of $6.0M, before additional R&D is considered. That cost structure explains why a 23.9% gross margin still translated into a -29.1% operating margin; gross profit did not scale into earnings.

Short-term financing became more demanding: current liabilities rose from $1.5M in FY2024 to $14.9M in FY2025. The current ratio fell from 18.4x to 1.7x, so the balance sheet moved from substantial current-asset excess toward a much narrower working-capital buffer.

Financial Health Signals

Financial health score not available

Amplitech Group, Inc. Series B Right does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

2/8

Amplitech Group, Inc. Series B Right passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

Amplitech Group, Inc. Series B Right reported a net loss of $7.0M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Amplitech Group, Inc. Series B Right reported an operating loss of $7.3M against $160K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$8.1M

YoY-26.8%

QoQ+50.9%

5Y CAGR+51.1%

10Y CAGR+31.9%

Amplitech Group, Inc. Series B Right generated $8.1M in revenue in Q2 2026. This represents a decrease of 26.8% from the same quarter a year earlier. Against the prior quarter it is up 50.9%.

EBITDA

-$2.7M

YoY-59.1%

QoQ-144.3%

Amplitech Group, Inc. Series B Right's EBITDA was -$2.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 59.1% from the same quarter a year earlier. Against the prior quarter it is down 144.3%.

Net Income

-$3.1M

YoY-74.3%

QoQ-103.0%

Amplitech Group, Inc. Series B Right reported -$3.1M in net income in Q2 2026. This represents a decrease of 74.3% from the same quarter a year earlier. Against the prior quarter it is down 103.0%.

EPS (Diluted)

-$0.12

YoY-50.0%

QoQ-100.0%

Amplitech Group, Inc. Series B Right earned -$0.12 per diluted share (EPS) in Q2 2026. This represents a decrease of 50.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Cash & Balance Sheet

Cash & Debt

$8.9M

YoY+78.5%

QoQ-24.7%

5Y CAGR-20.3%

10Y CAGR+50.1%

Amplitech Group, Inc. Series B Right held $8.9M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

30M

YoY+46.0%

QoQ+18.6%

5Y CAGR+26.3%

10Y CAGR-4.2%

Amplitech Group, Inc. Series B Right had 30M shares outstanding in Q2 2026. This represents an increase of 46.0% from the same quarter a year earlier. Against the prior quarter it is up 18.6%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

27.9%

YoY+20.1pp

QoQ-20.1pp

5Y change-5.7pp

10Y change-42.3pp

Amplitech Group, Inc. Series B Right's gross margin was 27.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 20.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 20.1 percentage points.

Operating Margin

-39.6%

YoY-22.1pp

QoQ-9.3pp

5Y change+28.6pp

10Y change-71.2pp

Amplitech Group, Inc. Series B Right's operating margin was -39.6% in Q2 2026, reflecting core business profitability. This is down 22.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.3 percentage points.

Net Margin

-38.3%

YoY-22.2pp

QoQ-9.8pp

5Y change+7.9pp

10Y change-68.9pp

Amplitech Group, Inc. Series B Right's net profit margin was -38.3% in Q2 2026, showing the share of revenue converted to profit. This is down 22.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.8 percentage points.

Return on Equity

-6.6%

YoY-1.7pp

QoQ-3.5pp

5Y change-5.1pp

10Y change-106.7pp

Amplitech Group, Inc. Series B Right's ROE was -6.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.

Capital Allocation

R&D Spending

$1.4M

YoY+108.6%

QoQ+173.2%

5Y CAGR+89.8%

Amplitech Group, Inc. Series B Right invested $1.4M in research and development in Q2 2026. This represents an increase of 108.6% from the same quarter a year earlier. Against the prior quarter it is up 173.2%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

AMPGZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMPGZ quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$24.0M	$25.2M+165.0%	$9.5M-39.0%	$15.6M-19.6%	$19.4M+267.6%	$5.3M+52.6%	$3.5M+10.7%	$3.1M+30.2%	$2.4M+73.6%	$1.4M-32.2%	$2.0M+37.2%	$1.5M+16.4%	$1.3M+4.4%	$1.2M+23.2%	$992K+9.4%	$907K
Cost of Revenue	$6.0M	$292K-5.2%	$308K+20.2%	$256K+31.8%	$194K+104.4%	$95K-95.7%	$2.2M+41.6%	$1.6M+53.2%	$1.0M+55.8%	$652K-21.2%	$828K+10.1%	$752K+13.4%	$663K+14.5%	$579K-3.0%	$597K+71.5%	$348K
Gross Profit	$8.8M	$6.0M+73.0%	$3.5M-52.1%	$7.3M-18.5%	$8.9M+590.4%	$1.3M+3.1%	$1.3M-19.9%	$1.6M+13.4%	$1.4M+89.6%	$728K-39.8%	$1.2M+64.9%	$733K+19.6%	$613K-4.7%	$643K+62.9%	$395K-29.3%	$559K
R&D Expenses	$3.2M	$2.7M-25.2%	$3.6M+53.3%	$2.3M+128.7%	$1.0M-44.1%	$1.8M+2859.3%	$62K+9.6%	$57K+31.6%	$43K-37.3%	$68K+93.5%	$35K	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$14.0M	$10.7M+35.7%	$7.9M+4.6%	$7.5M-1.6%	$7.6M+67.1%	$4.6M+116.5%	$2.1M+42.1%	$1.5M+42.7%	$1.0M+27.0%	$818K+11.1%	$737K+14.0%	$647K-5.5%	$684K+4.4%	$655K+28.1%	$511K+6.6%	$480K
Operating Income	-$8.3M	-$7.3M+13.2%	-$8.4M-227.1%	-$2.6M-1807.5%	$151K+103.0%	-$5.1M-457.4%	-$916K-1217.0%	$82K-76.0%	$341K+479.0%	-$90K-119.1%	$472K+445.1%	$87K+222.2%	-$71K-509.1%	-$12K+90.0%	-$116K-247.6%	$79K
EBITDA	N/A	-$6.0M+23.6%	-$7.9M-285.6%	-$2.0M-463.5%	$563K+111.4%	-$5.0M-501.7%	-$824K-706.5%	$136K-64.3%	$380K+701.3%	-$63K-112.6%	$501K+331.0%	$116K+456.1%	-$33K-163.1%	$52K+182.5%	-$63K-274.7%	$36K
Interest Expense	$199K	$160K+154.9%	-$292K-1615.5%	$19K+48.2%	$13K-69.6%	$43K-60.9%	$110K+1425.6%	$7K-42.2%	$12K+78.8%	$7K-55.5%	$16K-57.2%	$37K-81.7%	$200K+133.3%	$86K+12.0%	$77K+231.3%	-$58K
Income Tax	N/A	$13K-13.3%	$15K-37.5%	$24K	$0	$0	$0	$0	N/A	N/A	$41K	N/A	N/A	N/A	N/A	N/A
Net Income	-$8.0M	-$7.0M+37.7%	-$11.2M-356.0%	-$2.5M-264.1%	-$677K+85.8%	-$4.8M-364.0%	-$1.0M-17350.8%	$6K-98.2%	$329K+439.0%	-$97K-121.3%	$456K+811.7%	$50K+106.5%	-$770K-432.9%	-$144K+25.1%	-$193K-2058.7%	$10K
EPS (Basic)	N/A	-$0.33+68.3%	-$1.04-300.0%	-$0.26-271.4%	-$0.07+86.8%	-$0.53-43.2%	-$0.37	$0.00	$0.00	$0.00-100.0%	$0.01	$0.00+100.0%	-$0.02-100.0%	-$0.010.0%	-$0.01	N/A
EPS (Diluted)	-$0.33	-$0.33	-$1.04	-$0.26-271.4%	-$0.07+86.8%	-$0.53	-$0.37	$0.00	$0.00	$0.00-100.0%	$0.01	$0.00+100.0%	-$0.02	N/A	-$0.01	N/A
Diluted Shares (Avg)	N/A	21M	11M	10M+0.5%	10M+8.0%	9M	3M	4M-94.9%	88M+90.0%	46M-46.2%	86M0.0%	86M+167.7%	32M	20M+12.0%	18M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$8.1M-26.8%	$5.3M+48.6%	$4.5M+141.6%	$6.1M+115.0%	$11.0M+336.2%	$3.6M+56.9%	$1.9M-53.8%	$2.8M-16.3%
Cost of Revenue	$5.8M+7795.5%	$77K+4.4%	$77K-18.8%	$68K-4.6%	$74K+3.6%	$74K+3.4%	$95K+33.3%	$71K+3.4%
Gross Profit	$2.3M+161.2%	$2.6M+116.1%	$1.0M+416.4%	$3.0M+119.6%	$863K-18.4%	$1.2M+34.6%	$197K-90.4%	$1.3M-9.1%
R&D Expenses	$1.4M+108.6%	$503K-32.0%	$589K-74.2%	$699K+22.2%	$659K+43.2%	$740K+167.3%	$2.3M+162.3%	$572K+34.5%
SG&A Expenses	$4.1M+91.4%	$3.7M+57.5%	$3.7M+107.1%	$2.5M+33.1%	$2.1M-1.7%	$2.3M+15.0%	$1.8M+5.0%	$1.9M-6.1%
Operating Income	-$3.2M-66.0%	-$1.6M+14.3%	-$3.3M+24.4%	-$221K+79.7%	-$1.9M-22.8%	-$1.9M-32.4%	-$4.3M-730.7%	-$1.1M-17.4%
EBITDA	-$2.7M-59.1%	-$1.1M+38.5%	-$2.8M+34.4%	$160K+116.7%	-$1.7M-16.0%	-$1.8M-36.1%	-$4.2M-1094.1%	-$959K-20.1%
Interest Expense	$58K+99.6%	$59K+20.1%	$49K+127.3%	$33K+132.6%	$29K+456.7%	$49K+1239.7%	-$179K-16856.6%	-$101K-13359.3%
Net Income	-$3.1M-74.3%	-$1.5M+17.3%	-$3.2M+16.1%	-$188K+84.2%	-$1.8M-12.4%	-$1.8M+60.5%	-$3.8M-630.6%	-$1.2M-34.0%
EPS (Basic)	-$0.12-50.0%	-$0.06+33.3%	-$0.14+50.0%	-$0.01+91.7%	-$0.08+50.0%	-$0.09+81.3%	-$0.28-366.7%	-$0.12-33.3%
EPS (Diluted)	-$0.12-50.0%	-$0.06+33.3%	-$0.14	-$0.01	-$0.08	-$0.09	-$0.28	-$0.12-33.3%
Diluted Shares (Avg)	25M+21.0%	24M+19.5%	N/A	21M	21M	20M	N/A	10M+3.5%

Not reported in any period shown, so not listed: Income Tax.

AMPGZ Balance Sheet

AMPGZ quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$51.5M+19.1%	$43.2M+37.6%	$31.4M-14.4%	$36.7M+4.1%	$35.2M+1153.0%	$2.8M-16.3%	$3.4M+138.7%	$1.4M+111.5%	$666K-15.0%	$783K+63.0%	$480K+8.0%	$444K-16.7%	$534K+29.7%	$412K-23.2%	$536K
Current Assets	$25.1M-11.5%	$28.3M+65.2%	$17.1M-22.6%	$22.2M-8.7%	$24.3M+1639.4%	$1.4M-25.6%	$1.9M+54.3%	$1.2M+100.9%	$605K-13.6%	$701K+82.5%	$384K+18.7%	$323K-13.6%	$374K+99.0%	$188K-55.6%	$424K
Cash & Equivalents	$5.0M-74.2%	$19.3M+187.2%	$6.7M-49.4%	$13.3M-26.2%	$18.0M+8930.4%	$200K-65.3%	$575K+30.0%	$442K+274.7%	$118K-58.4%	$284K+478.5%	$49K+155.9%	$19K+80.4%	$11K-61.7%	$28K-48.7%	$54K
Short-Term Investments	$0	$0	$0-100.0%	$247K	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$8.9M+17.4%	$7.6M+16.1%	$6.5M-1.4%	$6.6M+58.2%	$4.2M+710.5%	$517K-7.2%	$558K+42.6%	$391K+16.5%	$336K+25.7%	$267K+83.1%	$146K-11.0%	$164K+27.9%	$128K+13.5%	$113K-43.6%	$200K
Accounts Receivable	$3.3M+166.5%	$1.3M-50.6%	$2.5M+41.1%	$1.8M+8.5%	$1.7M+364.9%	$357K-42.3%	$619K+136.3%	$262K+90.6%	$137K-6.0%	$146K-16.9%	$176K+31.8%	$133K-25.4%	$179K+290.6%	$46K-62.4%	$122K
Long-Term Investments	$348K0.0%	$348K0.0%	$348K0.0%	$348K+39.3%	$250K	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M-2.5%	$4.8M+3909.6%	$120K0.0%	$120K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$18.6M+224.9%	$5.7M+21.2%	$4.7M-40.3%	$7.9M+27.9%	$6.2M+161.2%	$2.4M+4.6%	$2.3M+360.2%	$493K+198.2%	$165K-10.8%	$185K-45.4%	$339K-4.1%	$353K-53.1%	$754K-20.7%	$950K+7.1%	$887K
Current Liabilities	$14.9M+870.5%	$1.5M+2.4%	$1.5M-62.7%	$4.0M+5.3%	$3.8M+483.0%	$654K+25.6%	$521K+37.6%	$379K+129.2%	$165K-10.8%	$185K-45.4%	$339K-4.1%	$353K-49.4%	$698K-11.4%	$788K+10.2%	$715K
Non-Current Liabilities	$3.7M-11.4%	$4.2M+29.9%	$3.2M-17.4%	$3.9M+64.3%	$2.4M+38.5%	$1.7M-1.7%	$1.7M+1432.2%	$114K	$0	$0	$0	$0-100.0%	$56K-65.7%	$162K-5.9%	$173K
Long-Term Debt	N/A	N/A	$81K-65.4%	$234K	N/A	$1.6M+7.4%	$1.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$32.9M-12.3%	$37.5M+40.5%	$26.7M-7.2%	$28.8M-1.0%	$29.0M+6494.3%	$440K-59.7%	$1.1M+19.5%	$915K+82.9%	$500K-16.2%	$597K+323.3%	$141K+55.0%	$91K+141.4%	-$220K+59.1%	-$539K-53.3%	-$351K
Retained Earnings	-$28.0M-33.3%	-$21.0M-115.1%	-$9.8M-33.8%	-$7.3M-10.2%	-$6.6M-254.7%	-$1.9M-121.7%	-$843K+0.7%	-$849K+27.9%	-$1.2M-9.0%	-$1.1M+29.7%	-$1.5M+3.2%	-$1.6M-94.3%	-$817K-21.5%	-$672K-38.4%	-$486K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$58.5M+20.3%	$59.7M+42.0%	$51.5M+19.1%	$47.2M+71.5%	$48.6M+91.4%	$42.1M+56.5%	$43.2M+37.6%	$27.5M-15.6%
Current Assets	$31.2M+24.9%	$33.2M+23.8%	$25.1M-11.5%	$21.6M+70.8%	$25.0M+114.8%	$26.8M+108.6%	$28.3M+65.2%	$12.6M-30.0%
Cash & Equivalents	$8.9M+78.5%	$11.8M-30.3%	$5.0M-74.2%	$8.4M+679.1%	$5.0M+391.1%	$16.9M+612.8%	$19.3M+187.2%	$1.1M-80.3%
Short-Term Investments	$4.1M	$6.6M	$0	$0	$0	$0	$0	$0
Inventory	$9.6M+21.6%	$9.9M+38.0%	$8.9M+17.4%	$8.9M+17.6%	$7.9M+4.3%	$7.1M-1.4%	$7.6M+16.1%	$7.5M+14.2%
Accounts Receivable	$6.3M+16.5%	$3.8M+72.0%	$3.3M+166.5%	$3.4M+166.5%	$5.4M+371.0%	$2.2M+69.8%	$1.3M-50.6%	$1.3M-30.6%
Long-Term Investments	$348K0.0%	$348K0.0%	$348K0.0%	$348K0.0%	$348K0.0%	$348K0.0%	$348K0.0%	$348K
Goodwill	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%	$4.7M0.0%
Total Liabilities	$11.8M-8.4%	$11.4M+81.0%	$18.6M+224.9%	$11.4M+59.3%	$12.8M+171.4%	$6.3M+33.6%	$5.7M+21.2%	$7.2M+29.7%
Current Liabilities	$8.3M-6.2%	$7.8M+252.3%	$14.9M+870.5%	$7.6M+194.5%	$8.9M+435.7%	$2.2M+41.4%	$1.5M+2.4%	$2.6M+18.2%
Non-Current Liabilities	$3.4M-13.3%	$3.6M-12.1%	$3.7M-11.4%	$3.8M-16.5%	$4.0M+29.0%	$4.1M+29.7%	$4.2M+29.9%	$4.6M+37.3%
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.1M+877.8%
Total Equity	$46.8M+30.6%	$48.4M+35.2%	$32.9M-12.3%	$35.8M+75.8%	$35.8M+73.1%	$35.8M+61.4%	$37.5M+40.5%	$20.4M-24.8%
Retained Earnings	-$32.6M-32.5%	-$29.5M-29.3%	-$28.0M-33.3%	-$24.8M-44.3%	-$24.6M-53.9%	-$22.9M-58.4%	-$21.0M-115.1%	-$17.2M-85.9%

AMPGZ Cash Flow Statement

AMPGZ quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$13.1M	-$8.7M-64.0%	-$5.3M-52.6%	-$3.5M-1.3%	-$3.4M-55.8%	-$2.2M-321.7%	-$521K-2505.5%	-$20K-105.7%	$352K+311.2%	-$167K-148.1%	$347K+1062.9%	$30K+155.4%	-$54K+71.5%	-$189K-400.1%	$63K+191.1%	-$69K
Depreciation & Amortization	N/A	$1.3M+139.9%	$539K+1.4%	$531K+28.9%	$412K+181.0%	$147K+59.7%	$92K+70.5%	$54K+38.8%	$39K+44.5%	$27K-6.9%	$29K-2.5%	$30K-22.5%	$38K-39.7%	$63K+17.7%	$54K+225.0%	-$43K
Stock-Based Compensation	N/A	$544K+5.1%	$518K+32.9%	$390K-2.4%	$399K-45.5%	$732K+467.7%	$129K+9.2%	$118K	N/A	N/A	N/A	N/A	$501K+735.3%	$60K	N/A	N/A
Capital Expenditures	N/A	$1.0M+2266.5%	$43K-95.6%	$973K+32.3%	$736K-30.8%	$1.1M+1385.2%	$72K+466.0%	$13K+19.5%	-$11K+97.1%	$5K-62.5%	$14K	N/A	N/A	N/A	$5K	N/A
Free Cash Flow	N/A	-$9.7M-81.7%	-$5.3M-20.1%	-$4.4M-6.8%	-$4.2M-27.5%	-$3.3M-450.1%	-$593K-1715.6%	-$33K-109.6%	$342K+298.4%	-$172K-151.8%	$332K	N/A	N/A	N/A	$58K	N/A
Investing Cash Flow	-$6.3M	-$5.8M-74.8%	-$3.3M-353.5%	-$726K+32.7%	-$1.1M+89.8%	-$10.6M-14712.8%	-$72K+89.5%	-$681K-6336.9%	-$11K-97.1%	-$5K+62.5%	-$14K-810.2%	-$2K	$0	$0+100.0%	-$5K+9.1%	-$6K
Financing Cash Flow	$17.3M	$6.8M-67.8%	$21.2M+994.5%	-$2.4M-955.8%	-$224K-100.7%	$30.6M+13953.8%	$218K-73.9%	$834K+4835.5%	-$18K-369.8%	$7K+106.7%	-$98K-6061.1%	$2K-97.4%	$62K-63.6%	$171K+303.7%	-$84K-165.7%	$128K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$5.5M-146.0%	-$3.1M-56.3%	-$3.4M-193.5%	-$999K+42.3%	-$2.3M-70.6%	-$2.0M-86.6%	-$1.2M+31.6%	-$1.7M-240.2%
Depreciation & Amortization	$541K+111.4%	$532K+336.2%	$533K+255.1%	$381K+192.8%	$256K+98.1%	$122K-5.5%	$150K-12.6%	$130K+0.7%
Stock-Based Compensation	N/A	$633K+405.7%	N/A	N/A	N/A	$125K-9.8%	N/A	N/A
Capital Expenditures	N/A	N/A	$86K+419.0%	$443K+3371.4%	$126K+944.6%	$361K+22823.5%	$16K-60.4%	$13K-91.8%
Free Cash Flow	N/A	N/A	-$3.5M-196.6%	-$1.4M+17.4%	-$2.4M-78.5%	-$2.4M-119.8%	-$1.2M+32.2%	-$1.7M-162.7%
Investing Cash Flow	$2.0M+156.5%	-$6.6M-1722.5%	-$86K-419.0%	-$1.7M-13096.1%	-$3.6M-29858.3%	-$361K+88.9%	-$16K-100.5%	-$13K+93.4%
Financing Cash Flow	$686K+10320.2%	$9.8M+259752.8%	$6.8M-64.9%	$11K-99.4%	-$7K+78.3%	-$4K+82.6%	$19.4M+47812.4%	$1.8M+4594.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AMPGZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMPGZ quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	23.9%-12.7pp	36.6%-10.0pp	46.7%+0.7pp	46.0%+21.5pp	24.5%-11.8pp	36.3%-13.9pp	50.1%-7.5pp	57.6%+4.9pp	52.8%-6.6pp	59.4%+10.0pp	49.4%+1.3pp	48.0%-4.6pp	52.6%+12.8pp	39.8%-21.8pp	61.6%
Operating Margin	-29.0%+59.6pp	-88.7%-72.1pp	-16.5%-17.3pp	0.8%+97.6pp	-96.8%-70.3pp	-26.5%-29.1pp	2.6%-11.6pp	14.2%+20.8pp	-6.5%-29.7pp	23.2%+17.3pp	5.8%+11.4pp	-5.5%-4.6pp	-0.9%+10.8pp	-11.7%-20.4pp	8.7%
Net Margin	-27.8%	-118.2%	-15.8%-12.3pp	-3.5%+86.7pp	-90.2%-60.6pp	-29.7%-29.8pp	0.2%-13.5pp	13.7%+20.8pp	-7.0%-29.4pp	22.4%+19.0pp	3.4%+63.7pp	-60.4%-48.5pp	-11.8%+7.6pp	-19.4%-20.5pp	1.1%
Return on Equity	-21.3%+8.7pp	-30.0%-20.8pp	-9.2%-6.9pp	-2.4%+14.0pp	-16.4%+216.5pp	-232.9%-233.5pp	0.5%-35.4pp	35.9%+55.3pp	-19.4%-95.8pp	76.4%+40.9pp	35.5%+881.0pp	-845.6%	N/A	N/A	N/A
Return on Assets	-13.6%+12.4pp	-26.0%-18.2pp	-7.8%-6.0pp	-1.8%+11.7pp	-13.5%+23.0pp	-36.5%-36.7pp	0.2%-23.2pp	23.4%+38.0pp	-14.6%-72.9pp	58.3%+47.9pp	10.4%+183.7pp	-173.3%-146.2pp	-27.1%+19.8pp	-46.9%-48.7pp	1.8%
Current Ratio	1.68-16.8x	18.45+7.0x	11.44+5.9x	5.52-0.8x	6.36+4.2x	2.13-1.5x	3.60+0.4x	3.21-0.5x	3.66-0.1x	3.78+2.7x	1.13+0.2x	0.91+0.4x	0.54+0.3x	0.24-0.4x	0.59
Debt-to-Equity	0.57+0.4x	0.15+0.1x	0.000.0x	0.01-0.2x	0.21-3.4x	3.64+2.3x	1.37+0.8x	0.54+0.2x	0.330.0x	0.31-2.1x	2.40-1.5x	3.88	N/A	N/A	N/A
Asset Turnover	0.49+0.3x	0.22-0.3x	0.500.0x	0.53+0.4x	0.15-1.1x	1.23+0.3x	0.93-0.8x	1.70-0.4x	2.07-0.5x	2.60-0.5x	3.09+0.2x	2.87+0.6x	2.29-0.1x	2.41+0.7x	1.69
FCF Margin	-38.5%+17.6pp	-56.1%-27.6pp	-28.5%-7.1pp	-21.4%+40.4pp	-61.9%-44.7pp	-17.2%-16.1pp	-1.1%-15.3pp	14.2%+26.7pp	-12.5%-28.8pp	16.3%	N/A	N/A	N/A	5.8%	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	27.9%+20.1pp	48.0%+15.0pp	22.8%+12.1pp	48.6%+1.0pp	7.8%-34.0pp	33.0%-5.5pp	10.7%-40.6pp	47.5%+3.8pp
Operating Margin	-39.6%-22.1pp	-30.3%+22.2pp	-73.3%	-3.6%+34.8pp	-17.5%+44.6pp	-52.5%+9.8pp	-234.5%	-38.4%-11.0pp
Net Margin	-38.3%-22.2pp	-28.4%+22.7pp	-71.6%	-3.1%+38.9pp	-16.1%+46.3pp	-51.1%	-206.2%	-42.0%-15.8pp
Return on Equity	-6.6%-1.7pp	-3.1%+2.0pp	-9.8%+0.4pp	-0.5%+5.3pp	-5.0%+2.7pp	-5.1%+15.9pp	-10.2%-8.2pp	-5.8%-2.6pp
Return on Assets	-5.3%-1.6pp	-2.5%+1.8pp	-6.2%+2.6pp	-0.4%+3.9pp	-3.6%+2.6pp	-4.4%+13.0pp	-8.8%-7.2pp	-4.3%-1.6pp
Current Ratio	3.76+0.9x	4.25-7.9x	1.68-16.8x	2.85-2.1x	2.82-4.2x	12.10+3.9x	18.45+7.0x	4.91-3.4x
Debt-to-Equity	0.25-0.1x	0.24+0.1x	0.57+0.4x	0.32+0.3x	0.36+0.4x	0.18+0.2x	0.15+0.1x	0.06+0.1x
Asset Turnover	0.14-0.1x	0.090.0x	0.090.0x	0.130.0x	0.23+0.1x	0.090.0x	0.04-0.1x	0.100.0x
FCF Margin	N/A	N/A	-78.4%-14.5pp	-23.7%+37.9pp	-21.6%+31.1pp	-65.8%-18.8pp	-63.9%-20.3pp	-61.6%-42.0pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Where Amplitech Group, Inc. Series B Right Ranks

Frequently Asked Questions

What is Amplitech Group, Inc. Series B Right's annual revenue?

Amplitech Group, Inc. Series B Right (AMPGZ) reported $25.2M in total revenue for fiscal year 2025. This represents a 165.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Amplitech Group, Inc. Series B Right's revenue growing?

Amplitech Group, Inc. Series B Right (AMPGZ) revenue grew by 165.0% year-over-year, from $9.5M to $25.2M in fiscal year 2025.

Is Amplitech Group, Inc. Series B Right profitable?

No, Amplitech Group, Inc. Series B Right (AMPGZ) reported a net income of -$7.0M in fiscal year 2025, with a net profit margin of -27.8%.

What is Amplitech Group, Inc. Series B Right's EBITDA?

Amplitech Group, Inc. Series B Right (AMPGZ) had EBITDA of -$6.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Amplitech Group, Inc. Series B Right's gross margin?

Amplitech Group, Inc. Series B Right (AMPGZ) had a gross margin of 23.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Amplitech Group, Inc. Series B Right's operating margin?

Amplitech Group, Inc. Series B Right (AMPGZ) had an operating margin of -29.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Amplitech Group, Inc. Series B Right's net profit margin?

Amplitech Group, Inc. Series B Right (AMPGZ) had a net profit margin of -27.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Amplitech Group, Inc. Series B Right's return on equity (ROE)?

Amplitech Group, Inc. Series B Right (AMPGZ) has a return on equity of -21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Amplitech Group, Inc. Series B Right's free cash flow?

Amplitech Group, Inc. Series B Right (AMPGZ) recorded an outflow of $9.7M in free cash flow during fiscal year 2025. This represents a -81.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Amplitech Group, Inc. Series B Right's operating cash flow?

Amplitech Group, Inc. Series B Right (AMPGZ) recorded an outflow of $8.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Amplitech Group, Inc. Series B Right's total assets?

Amplitech Group, Inc. Series B Right (AMPGZ) had $51.5M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Amplitech Group, Inc. Series B Right's capital expenditures?

Amplitech Group, Inc. Series B Right (AMPGZ) invested $1.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Amplitech Group, Inc. Series B Right spend on research and development?

Amplitech Group, Inc. Series B Right (AMPGZ) invested $2.7M in research and development during fiscal year 2025.

How many shares does Amplitech Group, Inc. Series B Right have outstanding?

Amplitech Group, Inc. Series B Right (AMPGZ) had 25M shares outstanding as of fiscal year 2025.

What is Amplitech Group, Inc. Series B Right's current ratio?

Amplitech Group, Inc. Series B Right (AMPGZ) had a current ratio of 1.68 as of fiscal year 2025, which is generally considered healthy.

What is Amplitech Group, Inc. Series B Right's debt-to-equity ratio?

Amplitech Group, Inc. Series B Right (AMPGZ) had a debt-to-equity ratio of 0.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Amplitech Group, Inc. Series B Right's return on assets (ROA)?

Amplitech Group, Inc. Series B Right (AMPGZ) had a return on assets of -13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Amplitech Group, Inc. Series B Right's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Amplitech Group, Inc. Series B Right (AMPGZ) held $5.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.7M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Amplitech Group, Inc. Series B Right's Piotroski F-Score?

Amplitech Group, Inc. Series B Right (AMPGZ) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Amplitech Group, Inc. Series B Right's earnings high quality?

Amplitech Group, Inc. Series B Right (AMPGZ) reported a net loss of $7.0M while operations used $8.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Amplitech Group, Inc. Series B Right cover its interest payments?

Amplitech Group, Inc. Series B Right (AMPGZ) reported an operating loss of $7.3M against $160K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.